Ken Griffin
THRN

Ken Griffin’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Ken Griffin’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-200
Closed -$924 – 15575
2023
Q1 		$924 Buy
+200
New +$880 ﹤0.01% 14398

Other funds holding THRN

EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ken Griffin's THRN Position: Q2 2023 in Review

Ken Griffin sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q2 2023, closing a stake of 19,453 shares — an estimated $89.9K sold.

Ken Griffin first reported a position in THRN in Q3 2021 and held it in 4 quarters. The position peaked at $244K in Q3 2021. 44 funds tracked by Wall St. Rank hold THRN as of Q2 2023.

  • Ken Griffin reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Ken Griffin sold 19,453 Thorne Healthtech, Inc. Common Stock shares in Q2 2023, an estimated $89.9K.
  • Ken Griffin first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • Ken Griffin's Thorne Healthtech, Inc. Common Stock position peaked at $244K in Q3 2021.
  • 44 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.